MicroTransponder

Home
MicroTransponder

MicroTransponder is a medical device company developing solutions to restore independence and dignity.

A global medical device company, MicroTransponder®, is currently introducing the FDA-cleared Vivistim® Paired VNS™ System, a first-of-its-kind, clinically proven medical technology that generates two to three times more improvement in upper limb function than rehabilitation alone for stroke survivors after six weeks of in-clinic therapy. MicroTransponder is also developing paired VNS applications for tinnitus and other neurological conditions that impair sensory and motor function.

10/04/2025

During the Octane OC Neuro Tech Forum, our CEO, Richard Foust, was featured on the Converging and Emerging Markets for Neurotechnology panel and highlighted 3️⃣ insights gleaned from Vivistim's commercialization journey.

1️⃣ Neurotechnology is expanding workflow, diagnostic and treatment paradigms for patients through bioelectric medicine, AI and brain-computer interface (BCI).

2️⃣ We have to evolve the care pathway for neuro-disease identification and treatment.

3️⃣ The convergence of emerging technology will be the key driver for innovation.

Moderated by Bill Patterson, Ph.D., (VP of Innovation & Technology, Medtronic), the panel also included Ariane Tom, PhD (Founder & Managing Director, Kaleida Capital), and Daniel Levangie (President & CEO, CereVasc).

Address

Website

http://www.microtransponder.com/

Alerts

Be the first to know and let us send you an email when MicroTransponder posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MicroTransponder:

Shortcuts